Cargando…

Adenosine Receptors As Drug Targets for Treatment of Pulmonary Arterial Hypertension

Pulmonary arterial hypertension (PAH) is a clinical condition characterized by pulmonary arterial remodeling and vasoconstriction, which promote chronic vessel obstruction and elevation of pulmonary vascular resistance. Long-term right ventricular (RV) overload leads to RV dysfunction and failure, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alencar, Allan K. N., Montes, Guilherme C., Barreiro, Eliezer J., Sudo, Roberto T., Zapata-Sudo, Gisele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722832/ https://www.ncbi.nlm.nih.gov/pubmed/29255415 http://dx.doi.org/10.3389/fphar.2017.00858

Ejemplares similares

Synergistic interaction between a PDE5 inhibitor (sildenafil) and a new adenosine A(2A) receptor agonist (LASSBio-1359) improves pulmonary hypertension in rats
por: Alencar, Allan K., et al.
Publicado: (2018)

Human Mesenchymal Stem Cell Therapy Reverses Su5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Mice
por: Alencar, Allan K. N., et al.
Publicado: (2018)

Adenosine A(2A) receptor agonist prevents cardiac remodeling and dysfunction in spontaneously hypertensive male rats after myocardial infarction
por: da Silva, Jaqueline S, et al.
Publicado: (2017)

ROCK Inhibition as Potential Target for Treatment of Pulmonary Hypertension
por: Montagnoli, Tadeu L., et al.
Publicado: (2021)

Novel p38 Mitogen-Activated Protein Kinase Inhibitor Reverses Hypoxia-Induced Pulmonary Arterial Hypertension in Rats
por: Silva, Grazielle Fernandes, et al.
Publicado: (2022)

Therapeutic Benefit of the Association of Lodenafil with Mesenchymal Stem Cells on Hypoxia-induced Pulmonary Hypertension in Rats
por: da Silva, Marina de Moraes Carvalho, et al.
Publicado: (2020)

Novel agonist of α(4)β(2)* neuronal nicotinic receptor with antinociceptive efficacy in rodent models of acute and chronic pain
por: Sudo, Roberto T, et al.
Publicado: (2018)

Targeting Adenosine Receptors for the Treatment of Cardiac Fibrosis
por: Vecchio, Elizabeth A., et al.
Publicado: (2017)

Riociguate: Uma Alternativa para Tratar a Hipertensão Pulmonar
por: Zapata-Sudo, Gisele
Publicado: (2022)

Adenosine and P1 receptors: Key targets in the regulation of sleep, torpor, and hibernation
por: Ma, Wei-Xiang, et al.
Publicado: (2023)

The Role of Adenosine Receptors in Psychostimulant Addiction
por: Ballesteros-Yáñez, Inmaculada, et al.
Publicado: (2018)

Adenosine Kinase on Deoxyribonucleic Acid Methylation: Adenosine Receptor-Independent Pathway in Cancer Therapy
por: Luo, Hao-Yun, et al.
Publicado: (2022)

Text Mining-Based Drug Discovery for Connective Tissue Disease–Associated Pulmonary Arterial Hypertension
por: Tan, Jiang-Shan, et al.
Publicado: (2022)

Corrigendum: Adenosine kinase on deoxyribonucleic acid methylation: Adenosine receptor-independent pathway in cancer therapy
por: Luo, Hao-Yun, et al.
Publicado: (2023)

Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors
por: Sebastião, Ana M., et al.
Publicado: (2018)

Adenosine Metabotropic Receptors in Chronic Pain Management
por: Luongo, Livio, et al.
Publicado: (2021)

Molecular Evidence of Adenosine Deaminase Linking Adenosine A(2A) Receptor and CD26 Proteins
por: Moreno, Estefanía, et al.
Publicado: (2018)

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension
por: Chen, Yong-Jie, et al.
Publicado: (2021)

The Role of Trabectedin in Soft Tissue Sarcoma
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats
por: Tong, Yi, et al.
Publicado: (2018)

Therapy for Pulmonary Arterial Hypertension: Glance on Nitric Oxide Pathway
por: Tettey, Abraham, et al.
Publicado: (2021)

Phenotyping of Mice with Heart Specific Overexpression of A(2A)-Adenosine Receptors: Evidence for Cardioprotective Effects of A(2A)-Adenosine Receptors
por: Boknik, Peter, et al.
Publicado: (2018)

An Open Question: Is the A(2A) Adenosine Receptor a Novel Target for Alzheimer’s Disease Treatment?
por: Merighi, Stefania, et al.
Publicado: (2021)

Adenosine A2A Receptor: A New Neuroprotective Target in Light-Induced Retinal Degeneration
por: Soliño, Manuel, et al.
Publicado: (2022)

Relações entre a Redução de Estrogênio, Obesidade e Insuficiência Cardíaca com Fração de Ejeção Preservada
por: de Alencar, Allan Kardec Nogueira, et al.
Publicado: (2021)

Vasodilator Activity of the Essential Oil from Aerial Parts of Pectis brevipedunculata and Its Main Constituent Citral in Rat Aorta
por: Pereira, Sharlene Lopes, et al.
Publicado: (2013)

New hope for Nutlin-3a therapy for pulmonary arterial hypertension
por: Fukumoto, Jutaro, et al.
Publicado: (2013)

Traditional Herbal Medicine Discovery for the Treatment and Prevention of Pulmonary Arterial Hypertension
por: Xue, Zhifeng, et al.
Publicado: (2021)

Survivin inhibition with YM155 ameliorates experimental pulmonary arterial hypertension
por: Blanco, Isabel, et al.
Publicado: (2023)

Cost-effectiveness analysis of selexipag for the combined treatment of pulmonary arterial hypertension
por: Dong, Wenxing, et al.
Publicado: (2023)

Adenosine Receptor-Mediated Cardioprotection—Current Limitations and Future Directions
por: Lasley, Robert D.
Publicado: (2018)

Evidence for Arrhythmogenic Effects of A(2A)-Adenosine Receptors
por: Boknik, Peter, et al.
Publicado: (2019)

Oral treatment with Euterpe oleracea Mart. (açaí) extract improves cardiac dysfunction and exercise intolerance in rats subjected to myocardial infarction
por: Zapata-Sudo, Gisele, et al.
Publicado: (2014)

Dapagliflozin has No Protective Effect on Experimental Pulmonary Arterial Hypertension and Pulmonary Trunk Banding Rat Models
por: Li, Huayang, et al.
Publicado: (2021)

Adenosine in the Thymus
por: Köröskényi, Krisztina, et al.
Publicado: (2017)

Alternative adenosine Receptor activation: The netrin-Adora2b link
por: Yuan, Xiaoyi, et al.
Publicado: (2022)

Update on the recent development of allosteric modulators for adenosine receptors and their therapeutic applications
por: Pasquini, Silvia, et al.
Publicado: (2022)

Adherence and treatment patterns of disease-specific drugs among patients with pulmonary arterial hypertension: A nationwide, new-user cohort study
por: Tsai, Cheng-Yu, et al.
Publicado: (2023)

Synthesis, solubility, plasma stability, and pharmacological evaluation of novel sulfonylhydrazones designed as anti-diabetic agents
por: Zapata-Sudo, Gisele, et al.
Publicado: (2016)

The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist
por: Montes, Guilherme Carneiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_uo9lqsdk91np57f7opc9p2kn5u